NASDAQ:DYN
Dyne Therapeutics
- Stock
Last Close
18.20
06/11 21:47
Market Cap
3.87B
Beta: 0.24
Volume Today
1.59M
Avg: 383.32K
PE Ratio
−6.54
PFCF: −7.34
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 194.50M - | 402.50M 106.94% | 521M 29.44% | 445M 14.59% | 222.50M 50% | ||||||
average payables | 272.50M - | 254M 6.79% | 312M 22.83% | 349.50M 12.02% | 183.76M 47.42% | 887K 99.52% | 2.35M 164.71% | 3.74M 59.09% | 4.64M 24.35% | 14.10M 203.50% | |
average receivables | 345M - | 336M 2.61% | 394M 17.26% | 449.50M 14.09% | 256.50M 42.94% | ||||||
book value per share | 23.99 - | 23.37 2.60% | 15.83 32.26% | 11.73 25.87% | -0.47 104.03% | 1.10 331.73% | 23.78 2,071.86% | 7.23 69.58% | 4.86 32.89% | 0.00 99.97% | |
capex per share | -2.20 - | -2.53 14.87% | -1.38 45.29% | -0.01 99.06% | -0.13 890.03% | -0.08 37.23% | -0.07 11.85% | -0.06 16.99% | -0.00 99.98% | ||
capex to depreciation | -0.45 - | -0.43 4.98% | -0.26 39.29% | -5.58 2,061.05% | -6.08 8.85% | -1.66 72.71% | -3.33 100.50% | -1.82 45.20% | -1.28 29.94% | ||
capex to operating cash flow | -2.93 - | -0.48 83.52% | -0.38 20.60% | 0.03 108.40% | 0.14 332.48% | 0.02 82.06% | 0.03 21.22% | 0.02 34.03% | 0.00 80.59% | ||
capex to revenue | -0.33 - | -0.24 26.93% | -0.44 85.49% | ||||||||
cash per share | 15.46 - | 4.84 68.69% | 14.78 205.27% | 2.45 83.41% | 0.79 67.89% | 1.14 45.08% | 23.99 2,001.33% | 7.40 69.15% | 4.93 33.43% | 0.00 99.96% | |
days of inventory on hand | 66.31 - | 107.45 62.05% | 71.21 33.73% | 55.40 22.20% | |||||||
days payables outstanding | 68.86 - | 52.55 23.68% | 53.13 1.09% | 45.69 14.00% | |||||||
days sales outstanding | 67.22 - | 174.26 159.23% | 103.14 40.81% | 370.05 258.78% | |||||||
debt to assets | 0.63 - | 0.63 0.15% | 0.69 8.90% | 0.72 4.15% | 0.08 - | 0.10 29.79% | 0.17 66.88% | ||||
debt to equity | 2.35 - | 2.50 6.16% | 4.40 76.21% | 4.44 0.89% | 0.09 - | 0.12 36.27% | 0.30 148.61% | ||||
dividend yield | 0.01 - | 0.01 7.31% | 0.01 20.37% | ||||||||
earnings yield | -0.02 - | 0.02 175.22% | -0.40 2,503.10% | 0.02 104.88% | -0.02 199.32% | -0.04 126.63% | -0.19 339.73% | -0.25 26.97% | -0.27 11.19% | -0.00 99.89% | |
enterprise value | 8.25B - | 9.77B 18.48% | 10.29B 5.27% | 11.94B 16.08% | 238.64M 98.00% | 291.72M 22.24% | 1.46M 99.50% | 436.95M 29,765.80% | 460.74M 5.44% | 793.70B 172,165.89% | |
enterprise value over ebitda | 28.24 - | 13.28 52.99% | 97.04 630.91% | 12.58 87.03% | -49.85 496.23% | -20.00 59.89% | -0.02 99.88% | -2.95 11,718.52% | -2.69 8.59% | -3.28K 121,516.61% | |
ev to operating cash flow | -133.02 - | 103.95 178.15% | 15.22 85.36% | 20.41 34.13% | -57.31 380.80% | -24.65 56.99% | -0.03 99.87% | -3.65 11,517.29% | -3.00 17.95% | -4.22K 140,567.91% | |
ev to sales | 5.63 - | 11.61 106.28% | 7.53 35.11% | 23.60 213.36% | |||||||
free cash flow per share | -0.49 - | -1.45 194.27% | 2.71 287.37% | 2.23 17.87% | -0.42 118.68% | -1.05 152.65% | -3.31 214.85% | -2.42 26.91% | -3.02 24.57% | -0.00 99.90% | |
free cash flow yield | -0.02 - | -0.06 194.27% | 0.11 287.37% | 0.09 17.87% | -0.02 118.68% | -0.04 152.65% | -0.16 258.32% | -0.20 29.10% | -0.26 27.80% | -0.00 99.91% | |
graham net net | -47.26 - | -59.30 25.49% | -66.61 12.32% | -54.73 17.84% | -0.49 99.11% | 0.95 296.15% | 23.23 2,333.79% | 6.27 73.00% | 3.89 38.00% | 0.00 99.98% | |
graham number | 16.94 - | 14.50 14.40% | 58.51 303.47% | 11.13 80.98% | 2.23 80.00% | 5.10 129.16% | 46.73 816.05% | 21.85 53.24% | 18.64 14.71% | 0.01 99.94% | |
income quality | 0.93 - | 1.88 103.16% | -0.55 129.00% | 7.70 1,511.94% | 0.87 88.76% | 0.80 7.98% | 0.78 1.75% | 0.80 2.35% | 0.91 14.13% | 0.80 12.75% | |
intangibles to total assets | 0.00 - | 0.08 3,141.04% | 0.06 17.70% | 0.07 5.59% | 0 100% | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -4.75 - | 0.12 102.47% | -1.02 973.60% | -0.67 34.68% | -959 143,284.47% | -148.10 - | -58.61 - | ||||
interest debt per share | 56.93 - | 62.68 10.10% | 74.45 18.78% | 55.86 24.97% | 0.00 100.00% | 0.03 - | 0.64 2,231.13% | 0.64 0.21% | 0.00 99.93% | ||
inventory turnover | 5.50 - | 3.40 38.29% | 5.13 50.89% | 6.59 28.54% | |||||||
invested capital | 2.35 - | 2.50 6.16% | 4.40 76.21% | 4.44 0.89% | 0.09 - | 0.12 36.27% | 0.30 148.61% | ||||
market cap | 3.01B - | 2.99B 0.79% | 3.08B 3.20% | 3.87B 25.58% | 246.76M 93.63% | 306.35M 24.15% | 302.32M 1.32% | 605.14M 100.17% | 602.41M 0.45% | 793.80B 131,670.84% | |
net current asset value | -5.54B - | -6.67B 20.56% | -8.02B 20.25% | -8.35B 4.01% | -4.99M 99.94% | 12.36M 347.72% | 334.35M 2,605.29% | 324.93M 2.82% | 202.05M 37.82% | 55.59M 72.49% | |
net debt to ebitda | 17.93 - | 9.22 48.60% | 67.95 637.22% | 8.50 87.49% | 1.70 80.04% | 1.00 40.90% | 5.13 411.45% | 1.13 77.88% | 0.83 26.98% | 0.39 53.05% | |
net income per share | -0.53 - | 0.40 175.22% | -9.61 2,503.10% | 0.47 104.88% | -0.47 199.32% | -1.06 126.63% | -4.08 286.37% | -2.93 28.11% | -3.18 8.38% | -0.00 99.88% | |
operating cash flow per share | -0.49 - | 0.75 252.83% | 5.24 596.85% | 3.61 31.09% | -0.40 111.17% | -0.92 128.92% | -3.23 249.93% | -2.35 27.28% | -2.96 25.83% | -0.00 99.89% | |
payables turnover | 5.30 - | 6.95 31.02% | 6.87 1.08% | 7.99 16.28% | |||||||
receivables turnover | 5.43 - | 2.09 61.42% | 3.54 68.96% | 0.99 72.13% | |||||||
research and ddevelopement to revenue | |||||||||||
return on tangible assets | -0.01 - | 0.00 178.59% | -0.10 2,260.05% | 0.01 106.82% | -0.58 8,502.07% | -0.82 41.53% | -0.17 79.81% | -0.35 110.97% | -0.54 53.81% | -1.43 164.95% | |
revenue per share | 11.63 - | 6.74 42.11% | 10.59 57.20% | 3.12 70.50% | |||||||
roe | -0.02 - | 0.02 177.23% | -0.61 3,647.54% | 0.04 106.58% | 0.99 2,366.45% | -0.96 197.80% | -0.17 82.21% | -0.41 136.33% | -0.65 61.49% | -2.58 294.71% | |
roic | -0.05 - | -0.00 98.47% | -0.06 8,022.73% | 0.01 109.52% | 0.98 18,277.43% | -0.90 191.51% | -0.17 81.14% | -0.35 104.44% | -0.54 54.97% | -1.66 208.99% | |
sales general and administrative to revenue | -0.07 - | 0.15 329.75% | 0.12 22.47% | 0.37 216.91% | |||||||
shareholders equity per share | 23.99 - | 23.37 2.60% | 15.83 32.26% | 11.73 25.87% | -0.47 104.03% | 1.10 331.73% | 23.78 2,071.86% | 7.23 69.58% | 4.86 32.89% | 0.00 99.97% | |
stock based compensation to revenue | 0.01 - | 0.03 156.58% | 0.02 31.76% | 0.09 283.17% | |||||||
tangible asset value | 3.00B - | 2.02B 32.51% | 1.21B 40.41% | 1.10B 8.38% | -4.88M 100.44% | 14.04M 387.68% | 342.37M 2,339.21% | 368.20M 7.54% | 252.36M 31.46% | 91.29M 63.83% | |
tangible book value per share | 23.78 - | 16.18 31.97% | 9.34 42.25% | 6.81 27.04% | -0.47 106.93% | 1.10 331.73% | 23.78 2,071.86% | 7.23 69.58% | 4.86 32.89% | 0.00 99.97% | |
working capital | 1.99B - | 1.13B 43.15% | 2.07B 82.79% | 475M 77.06% | 7.45M 98.43% | 12.40M 66.52% | 334.35M 2,596.13% | 353.67M 5.78% | 227.92M 35.55% | 78.28M 65.66% |
All numbers in USD (except ratios and percentages)